Pacer BioThreat Strategy ETF
VIRS
VIRS was delisted on the 10th of October, 2024.
4 hedge funds and large institutions have $4.25M invested in Pacer BioThreat Strategy ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
24,900% more capital invested
Capital invested by funds: $17K → $4.25M (+$4.23M)
300% more funds holding
Funds holding: 1 → 4 (+3)
75.95% more ownership
Funds ownership: 0% → 75.95% (+76%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$2.93M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$823K |
| 3 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$289K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$34.8K |
Top Sellers
VIRS Hedge Fund Activity: Q3 2020 in Review
4 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Pacer BioThreat Strategy ETF (VIRS) for Q3 2020, worth a combined $4.25M — up 24,900% from $17K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new VIRS positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was International Assets Investment Management, opening a new position worth an estimated $2.93M.
- 4 institutional investors held Pacer BioThreat Strategy ETF (VIRS) as of Q3 2020, up from 1 in Q2 2020.
- Funds reported $4.25M of Pacer BioThreat Strategy ETF stock for Q3 2020, up 24,900% quarter-over-quarter.
- 3 funds opened new Pacer BioThreat Strategy ETF positions in Q3 2020 and 0 closed out, a net change of +3 holders.
- The largest Pacer BioThreat Strategy ETF buyer in Q3 2020 was International Assets Investment Management, an estimated $2.93M added.
Based on aggregated 13F filings for Q3 2020.